As of 2026-01-05, the Intrinsic Value of Solid Biosciences Inc (SLDB) is -10.73 USD. This SLDB valuation is based on the model Peter Lynch Fair Value. With the current market price of 5.45 USD, the upside of Solid Biosciences Inc is -296.81%.
Based on its market price of 5.45 USD and our intrinsic valuation, Solid Biosciences Inc (SLDB) is overvalued by 296.81%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -10.73 - -10.73 | -10.73 | -296.81% |
| P/E | (16.52) - (31.45) | (23.11) | -524.1% |
| DDM - Stable | (18.81) - (67.62) | (43.21) | -892.9% |
| DDM - Multi | (0.23) - (0.62) | (0.34) | -106.2% |
| Market Cap (mil) | 424.61 |
| Beta | 1.87 |
| Outstanding shares (mil) | 77.91 |
| Enterprise Value (mil) | 363.53 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.42% |
| Cost of Debt | 5.00% |
| WACC | 9.40% |